Thermo Fisher (NYSE:TMO) said yesterday it inked a deal to pick up Becton Dickinson‘s (NYSE:BDX) Advanced Bioprocessing business for an undisclosed amount.
The divested assets include a technical services program with a variety of peptones intended to enhance cell culture media formulations to improve yield and reduce variability in biopharmaceutical applications, Thermo Fisher said.
